Mangiferin Ameliorates HFD-Induced NAFLD through Regulation of the AMPK and NLRP3 Inflammasome Signal Pathways

Nonalcoholic fatty liver disease (NAFLD) is closely related to glycolipid metabolism and liver inflammation. And there is no effective drug approved for its clinical therapy. In this study, we focused on mangiferin (Man) and explored its effects and mechanisms on NAFLD treatment based on the regulat...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhang Yong, Wang Ruiqi, Yao Hongji, Ma Ning, Jiang Chenzuo, Zhou Yu, Xia Zhixuan, Liu Qiang, Liu Qibing, Lu Weiying, Zhang Xiaopo
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2021/4084566
Tags: Add Tag
No Tags, Be the first to tag this record!